Estée Lauder takes stake in 111Skin to capture post-procedure care surge
The Estée Lauder Companies (ELC) has invested in 111Skin, a luxury clinical skin care brand. The minority investment comes as the industry is adapting to a rising demand for recovery care amid the increasing popularity of aesthetic treatments. 111Skin was founded by plastic and reconstructive surgeon Dr. Yannis Alexandrides in 2012 to accelerate his patients’ healing time following procedures.This Technical Paper is brought to you by Ashland.
In our interview at In-cosmetics Global 2026, Markus Schröder, R&D director at Cosphatec, discussed the company’s approach to using natural raw materials in formulations. He highlighted Cosphaderm Tocopharin, which functions as a preservative for products and an anti-aging, protective ingredient for skin care solutions. He told us how the ingredient leverages the properties of carnosic acid from rosemary plants to protect the skin from UV radiation.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Plant-based innovation trendsMay 2026
Multimedia
In our interview at In-cosmetics Global 2026, Markus Schröder, R&D director at Cosphatec, discussed the company’s approach to using natural raw materials in formulations. He highlighted Cosphaderm Tocopharin, which functions as a preservative for products and an anti-aging, protective...
































